Gemigliptin Tartrate(911637-19-9 free base)

Research use only, not for human use.

Gemigliptin tartrate is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4).

Gemigliptin tartrate is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties.

Gemigliptin tartrate dose-dependently inhibits the formation of AGE-BSA with IC50 of 11.69 mM.Gemigliptin tartrate dose-dependently suppresses the cross-linking of preformed AGE-BSA with rat tail tendon collagen with an IC50 of 1.39 mM.Gemigliptin tartrate is a competitive DPP-4 inhibitor with a Ki of 7.25 nM.

Gemigliptin tartrate (100 mg/kg; i.g.; daily; for 12 weeks) inhibits AGEs formation and AGE cross-links in vivo.Gemigliptin tartrate dose-dependently inhibits plasma DPP-4 activity in rats, dogs, and monkeys. Animal Model:Male C57BL/KsJ-db/db mice (7 weeks old)Dosage:100 mg/kg Administration:Oral gavage, daily, for 12 weeks Result:Significantly reduced circulating AGE levels by 44.5% in serum.

LC15-0444 tartrate

Metabolic Enzyme/Protease

DPP

DPP-4

——

——

1374639-74-3

639.45

C22H25F8N5O8

>98% (HPLC)

DMSO:90mg/ml(140.75mM; need ultrasonic)

O=C([C@@H]([C@H](C(O)=O)O)O)O.O=C1N(CC(F)(CC1)F)C[C@H](CC(N2CCC3=C(N=C(N=C3C2)C(F)(F)F)C(F)(F)F)=O)N

——

(-20℃)

With Ice Pack

≥ 2 years